Lufenuron
Inquiry
| Post Date: | Dec 02,2024 |
| Expiry Date: | May 31,2025 |
| Detailed Description: | Cas No. :103055-07-8 |
| CAS Registry Number: | 103055-07-8 |
| Synonyms: | ;fluphenacur;(rs)-1-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxyl)phenyl]3-(2,6-difluorobenzoyl)urea;cga-184,699;LUFENURON PESTANAL, 100 MG;Benzamide, N-2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylaminocarbonyl-2,6-difluoro-;lufenuron (bsi,iso,inn);(RS)-1-[2,5-Dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-3-(2,6-difluorobenzoyl)urea;N-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluorobenzamide;N-{[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl}-2,6-difluorobenzamide; |
| Molecular Formula: | C17H8Cl2F8N2O3 |
| Molecular Weight: | 511.1502 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xi:Irritant; N:Dangerous for the environment; |
| Risk Codes: | R43:; R50/53:; |
| Safety Description: | S2:; S24:; S37:; S60:; S61:; |
| Company: | WLP INGREDIENT INC [ China ] |
| Contact: | |
| Tel: | +86-18192489506 |
| Fax: | |
| Email: | neil.chai@wlpingredient.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
-
- L-Malate Sodium
- Epalrestat
- Moxonidine
- Vonoprazan Fumarate
- Trenbolone Acetate
- Estradiol Hemihydrate
- 16,17-a-epoxyprogesterone
- mebhidrolin(DIAZOLINE)
- Estradiol
- Sulfaquinoxaline sodium
- Sulfaclozine
- Sulfamethazine sodium salt
- Sulfadiazine
- Sulfamethazine
- Hydrocortisone
- Vitamin K3
- Vitamin D3
- Trimethoprim
- Diaveridine hydrochloride
- Enrofloxacin hydrochloride
- Difloxacin Hcl
- Sarafloxacin hydrochloride
- Flumequine sodium
- Toltrazuril
- Apramycin sulfate
